AR Zander

829 total citations
21 papers, 633 citations indexed

About

AR Zander is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, AR Zander has authored 21 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in AR Zander's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Response and Inflammation (5 papers). AR Zander is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Response and Inflammation (5 papers). AR Zander collaborates with scholars based in Germany, United States and Italy. AR Zander's co-authors include Nicolaus Kröger, William Krüger, W. Zeller, Dicke Ka, KB McCredie, Juliane Grimm, M. Hoffknecht, Berthold Schalke, Andrea Bacigalupo and K. Gutensohn and has published in prestigious journals such as Blood, British Journal of Cancer and Leukemia.

In The Last Decade

AR Zander

21 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AR Zander Germany 10 275 230 177 112 107 21 633
Stephen J. Forman United States 19 456 1.7× 298 1.3× 203 1.1× 185 1.7× 222 2.1× 34 962
Giuseppe Iodice Italy 15 285 1.0× 222 1.0× 118 0.7× 68 0.6× 187 1.7× 31 875
Pierre‐Yves Le Prise France 11 257 0.9× 194 0.8× 171 1.0× 185 1.7× 108 1.0× 14 633
RH van Oers Netherlands 11 317 1.2× 205 0.9× 404 2.3× 79 0.7× 181 1.7× 20 894
Sou‐Ming Chuang Taiwan 15 212 0.8× 168 0.7× 145 0.8× 190 1.7× 114 1.1× 25 681
Stern Ac Netherlands 10 590 2.1× 438 1.9× 210 1.2× 51 0.5× 90 0.8× 11 858
Tomoko Ohtsu Japan 16 126 0.5× 374 1.6× 198 1.1× 187 1.7× 176 1.6× 33 758
Klaus Fenchel Germany 14 133 0.5× 340 1.5× 287 1.6× 109 1.0× 258 2.4× 31 855
Maria Cristina Rapanotti Italy 14 313 1.1× 163 0.7× 144 0.8× 58 0.5× 171 1.6× 28 598
Katalin Pálóczi Hungary 14 187 0.7× 119 0.5× 238 1.3× 72 0.6× 125 1.2× 67 592

Countries citing papers authored by AR Zander

Since Specialization
Citations

This map shows the geographic impact of AR Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AR Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AR Zander more than expected).

Fields of papers citing papers by AR Zander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AR Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AR Zander. The network helps show where AR Zander may publish in the future.

Co-authorship network of co-authors of AR Zander

This figure shows the co-authorship network connecting the top 25 collaborators of AR Zander. A scholar is included among the top collaborators of AR Zander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AR Zander. AR Zander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szydlo, Richard, Maria Gilleece, Gunnar Juliusson, et al.. (2002). Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT.. Blood. 100(11). 542. 1 indexed citations
2.
Li, Z, Boris Fehse, Bernhard Schiedlmeier, et al.. (2002). Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia. 16(9). 1655–1663. 20 indexed citations
4.
Simonsson, Bengt, Thomas H. Tötterman, Peter Hokland, et al.. (2000). Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation. Bone Marrow Transplantation. 25(11). 1121–1127. 8 indexed citations
5.
Kühlcke, Klaus, Z Li, Christian Lindemann, et al.. (2000). Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation. Bone Marrow Transplantation. 25(S2). S96–S98. 7 indexed citations
6.
Krüger, William, Nicolaus Kröger, Carlos Salomón, et al.. (1999). Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases. Bone Marrow Transplantation. 23(6). 589–597. 75 indexed citations
7.
Kröger, Nicolaus, M. Hoffknecht, Mathias Hänel, et al.. (1998). Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplantation. 21(12). 1171–1175. 28 indexed citations
8.
Jung, R., William Krüger, Stefan B. Hosch, et al.. (1998). Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. British Journal of Cancer. 78(9). 1194–1198. 125 indexed citations
9.
Krüger, William, N. Fehse, Boris Fehse, et al.. (1998). Purging and haemopoietic progenitor cell selection by CD34+ cell separation. Bone Marrow Transplantation. 21(7). 665–671. 12 indexed citations
10.
Grimm, Juliane, W. Zeller, & AR Zander. (1998). Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD. Bone Marrow Transplantation. 21(1). 29–32. 53 indexed citations
11.
Marmont, A, Andrea Bacigalupo, Peter Dreger, et al.. (1996). Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood. 88(9). 3621–3625. 163 indexed citations
14.
Zander, AR, et al.. (1981). Adherent cell inhibition of human leukemic in vitro agar clonal growth by short-term cell-to-cell contact. Blood. 57(1). 71–74. 3 indexed citations
15.
16.
Gutterman, JU, et al.. (1979). Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood. 54(6). 1423–1427. 71 indexed citations
17.
Gutterman, JU, et al.. (1979). Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood. 54(6). 1423–1427. 3 indexed citations
18.
Spitzer, Gary, et al.. (1979). T lymphocyte and monocyte-macrophage interaction in colony-stimulating activity elaboration in man. Blood. 54(6). 1376–1383. 5 indexed citations
19.
Spitzer, Gary, et al.. (1979). T lymphocyte and monocyte-macrophage interaction in colony-stimulating activity elaboration in man. Blood. 54(6). 1376–1383. 27 indexed citations
20.
Gj, Elfenbein, WH Burns, LL Sensenbrenner, et al.. (1978). Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood. 52(3). 627–636. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026